SPYRE THERAPEUTICS, INC. Weighted Average Number of Shares Issued, Basic
SPYRE THERAPEUTICS, INC. (SYRE) reported Weighted Average Number of Shares Issued, Basic of 50.89 million shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2024-11-07
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for the quarter ending 2024-09-30 was 50.89M shares, a 1167.27% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for the quarter ending 2024-06-30 was 45.21M shares, a 1567.55% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for the quarter ending 2024-03-31 was 36.26M shares, a 1286.80% increase year-over-year.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for the quarter ending 2023-09-30 was 4.02M shares.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for fiscal 2023 was 6.20M shares, a 168.75% increase from fiscal 2022.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for fiscal 2022 was 2.31M shares, a 17.92% increase from fiscal 2021.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for fiscal 2021 was 1.96M shares, a 95.13% decline from fiscal 2020.
- SPYRE THERAPEUTICS, INC. weighted average number of shares issued, basic for fiscal 2020 was 40.22M shares.
| Period end | Weighted Average Number of Shares Issued, Basic 3 month | Weighted Average Number of Shares Issued, Basic 6 month | Weighted Average Number of Shares Issued, Basic 9 month | Weighted Average Number of Shares Issued, Basic 12 month | Weighted Average Number of Shares Issued, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | 50.89M shares 10-Q · filed 2024-11-07 | 44.15M shares 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 45.21M shares 10-Q · filed 2024-08-07 | 40.74M shares 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | 36.26M shares 10-Q · filed 2024-05-09 | ||||
| 2023-12-31 | 6.20M shares 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | 4.02M shares 10-Q · filed 2024-11-07 | 3.12M shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 2.71M shares 10-Q · filed 2024-08-07 | 2.66M shares 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | 2.61M shares 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | 2.31M shares 10-K · filed 2024-02-29 | 57.69M shares 10-K · filed 2023-03-02 | |||
| 2021-12-31 | 1.96M shares 10-K · filed 2024-02-29 | 48.92M shares 10-K · filed 2023-03-02 | |||
| 2020-12-31 | 40.22M shares 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |